Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BALAXI.NSthis companyBalaxi Pharmaceuticals Limited	₹22.66	60.27×	0.34×	0.31×	17.26×	-101.9%	41.7%	1.9%	0.5%	0.6%	0.4%	-52.9%	0.23×	5.79×	1.36×	4.51×	0.0%	5	2.08	1	D+
BACPHAR.BOBacil Pharma Limited	₹16.82	43×	2.7×	0×	-270.7×	-93.7%	0.0%	0.0%	0.0%	6.3%	-1.0%	1.1%	0×	2.32×	0×	0.68×	0.0%	2	2.81	3	B-
CRSTCHM.BOCrestchem Limited	₹100.20	8.61×	2.36×	0.79×	5.99×	406.9%	17.8%	10.5%	9.2%	27.4%	22.5%	18.1%	0×	-0.11×	314×	0.9×	0.7%	4	—	3	B
MEDICAPQ.BOMedi-Caps Limited	₹21.07	-9.51×	0.26×	2.32×	-3.02×	-58.8%	-37.2%	-90.1%	-24.4%	-2.7%	-9.9%	-27.0%	0×	0.05×	-862.95×	17.34×	0.0%	2	—	2	C
NGIND.BONG Industries Ltd.	₹100.10	24.68×	1.28×	2.61×	15.29×	268.2%	55.0%	7.3%	10.6%	5.2%	2.7%	3.8%	0.05×	0.08×	16.38×	1.55×	2.7%	3	12.09	2	C+
ROOPAIND.BORoopa Industries Limited	₹43.96	301.46×	1.42×	0.2×	13.38×	-1192.7%	9.9%	5.8%	0.1%	0.5%	7.2%	-4.3%	1.76×	7.39×	2.28×	1.25×	0.0%	5	—	2	C+
Peer median	—	24.68×	1.42×	0.79×	5.99×	-58.8%	9.9%	5.8%	0.1%	5.2%	2.7%	1.1%	0×	0.08×	2.28×	1.25×	0.0%	3	7.45	2	—